Cite
MLA Citation
Antonella Galeone et al.. “Suppression of tumorigenicity‐2 (ST2) is a promising biomarker in heart transplantation.” Clinical transplantation, vol. 36, no. 5, 2022, p. n/a. http://access.bl.uk/ark:/81055/vdc_100154262285.0x00001e